Control Bionics Limited
CBL
Rank in Stocks
#26772
Operating in Australia and North America, Control Bionics Limited and its... Operating in Australia and North America, Control Bionics Limited and its subsidiaries specialize in the innovation, development, and market introduction of sophisticated assistive communication technologies. The company's offerings include the NeuroNode Trilogy and NeuroNode3 systems, which empower individuals facing speech and mobility challenges to control computers for speech generation, electronic correspondence, leisure activities, and remote operation of other devices. Control Bionics also provides Cosmos Connect, a versatile interface capable of managing diverse equipment like wheelchairs, robotic dining aids, and gaming consoles. Additionally, they offer Uno Touch, a dedicated speech-generating device, alongside various other sensors for a broad spectrum of uses. Founded in 2005, the entity was initially named Control Bionics Holdings Pty Limited before rebranding as Control Bionics Limited in September 2020. The company's base of operations is situated in Camberwell, Australia.
Share Price
$0.03391731
Last synced: 2026-11-10
Market Cap
$18.46M
Change (1 day)
-2.00%
Change (1 year)
-29.76%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Control Bionics Limited (CBL)
Category
Healthcare
EPS for Control Bionics Limited (CBL)
EPS as of June 2026 TTM: $-0.01
According to Control Bionics Limited's latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2025 the company had an EPS of $-0.02, equal to its 2024 EPS of $-0.02.
EPS history for Control Bionics Limited from 2015 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.01 | -30.00% |
| 2025 | $-0.02 | -38.71% |
| 2024 | $-0.02 | -33.87% |
| 2023 | $-0.04 | -15.73% |
| 2022 | $-0.04 | 54.51% |
| 2021 | $-0.03 | 284.00% |
| 2020 | $-0.01 | -48.98% |
| 2019 | $-0.01 | 90.91% |
| 2018 | $-0.01 | -108.21% |
| 2016 | $0.09 | -35.58% |
| 2015 | $0.15 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -19,385.71% |
US
|
|
| $4.09 | -29,314.29% |
IE
|
|
| $9.45 | -67,600.00% |
US
|
|
| $2.37 | -17,028.57% |
US
|
|
| $1.77 | -12,742.86% |
US
|
Questions about Control Bionics Limited's earnings per share (EPS)
What is Control Bionics Limited's earnings per share (EPS)?
Control Bionics Limited's earnings per share (EPS) over the last twelve months is $-0.01, as of Jun 2026.
What was Control Bionics Limited's earnings per share (EPS) in 2025?
In 2025, Control Bionics Limited's earnings per share (EPS) was $-0.02, compared with $-0.02 in 2024.
How has Control Bionics Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Control Bionics Limited's earnings per share (EPS) was highest in 2020 ($-0.01) and lowest in 2023 ($-0.04).
How does Control Bionics Limited's earnings per share (EPS) compare with similar companies?
Control Bionics Limited's earnings per share (EPS) ($-0.01) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.